Mraz Amerine & Associates’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$275K Hold
3,000
0.04% 147
2026
Q1
$256K Sell
3,000
-300
-9% -$26.7K 0.04% 151
2025
Q4
$261K Hold
3,300
0.04% 151
2025
Q3
$264K Hold
3,300
0.04% 152
2025
Q2
$300K Buy
+3,300
New +$301K 0.05% 146

Other funds holding CL

Mraz Amerine & Associates's CL Position: Q2 2026 in Review

Mraz Amerine & Associates held its Colgate-Palmolive (CL) position steady in Q2 2026 at 3,000 shares worth $275K. The position accounts for 0.04% of the portfolio, ranked #147.

Mraz Amerine & Associates first reported a position in CL in Q2 2025 and has held it in 5 quarters since. The position peaked at $300K in Q2 2025. 658 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Mraz Amerine & Associates held 3,000 shares of Colgate-Palmolive worth $275K as of Q2 2026.
  • Mraz Amerine & Associates left its Colgate-Palmolive share count unchanged in Q2 2026.
  • Colgate-Palmolive made up 0.04% of Mraz Amerine & Associates's portfolio in Q2 2026, its #147 holding.
  • Mraz Amerine & Associates first reported a position in Colgate-Palmolive in Q2 2025 and has held it in 5 quarters since.
  • Mraz Amerine & Associates's Colgate-Palmolive position peaked at $300K in Q2 2025.
  • 658 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Mraz Amerine & Associates's 13F filing for Q2 2026, filed 16 Jul 2026.